'Hereditary angioedema hae' diaporamas de présentation

Information Centre for Rare Diseases and Orphan Drugs

601 views • 37 slides

Information Centre for Rare Diseases and Orphan Drugs

399 views • 37 slides

Revisiting the Need For Prophylaxis in Hereditary Angioedema

Revisiting the Need For Prophylaxis in Hereditary Angioedema. Prophylaxis for Hereditary Angioedema (HAE). Approved Therapies For HAE Prophylaxis. Abbreviations. References. References (cont). References (cont). References (cont).

197 views • 8 slides

C1 Esterase Inhibitor (Recombinant )

C1 Esterase Inhibitor (Recombinant ). Drugbank ID : DB09228 Molecular Weight (Daltons) : 67000 Half life : 2.4-2.7 hr Description :

69 views • 6 slides

HAE: When to Consider Self-Administration of Treatment

HAE: When to Consider Self-Administration of Treatment. Self-Administration of Therapies for Hereditary Angioedema (HAE). Patient Education For Patients With HAE. Abbreviations. References.

147 views • 5 slides

An Easy-to-Miss Diagnosis

An Easy-to-Miss Diagnosis. Hereditary Angioedema (HAE). The Onset of HAE. Abbreviations. References.

129 views • 5 slides

Hereditary Angioedema Market To Witness Widespread Expansion During 2026

44 views • 4 slides